# A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

> **NCT01391338** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 239 (actual)

## Conditions studied

- Chronic Abacterial Prostatitis
- Chronic Pelvic Pain Syndrome

## Interventions

- **DRUG:** ASP3652
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01391338
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2013-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391338, "A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01391338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*